henhaobio
Sign in

bioRxivPharmacology & ToxicologyPreprint

Human embryonic stem cell-derived cardiomyocytes express SARS-CoV-2 host entry proteins: screen to identify inhibitors of infection

T. L. Williams, M. T. Colzani, R. G. Macrae, E. L. Robinson, S. Bloor, E. J. Greenwood, J. R. Zhan, G. Strachan, R. E. Kuc, D. Nyimanu, J. J. Maguire, P. J. Lehner, S. Sinha, A. P. Davenport

PDFDOI

Abstract

Patients with cardiovascular comorbidities are more susceptible to severe infection with SARS-CoV-2, known to directly cause pathological damage to cardiovascular tissue. We outline a screening platform using human embryonic stem cell-derived cardiomyocytes, confirmed to express the protein machinery critical for SARS-CoV-2 infection, and a pseudotyped virus system. The method has allowed us to identify benztropine and DX600 as novel inhibitors of SARS-CoV-2 infection.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.